At Compass Oncology, our approach to treating prostate cancer begins with personalized care. This is why our prostate cancer doctors are committed to exploring new cancer treatments and diagnostic tools through cancer clinical trials and research. This allows our oncologists to provide treatment to their patients using the latest technologies and newest prostate cancer treatments.
Clinical trials are a key component of the cancer research process that helps doctors and researchers find out if new cancer treatments or combinations of therapies are more effective than the standard treatments currently available to patients. The more understanding there is regarding prostate cancer treatment, the better the care many patients are able to receive. This is what clinical trials aim to do.
Many clinical trials for prostate cancer test new drugs or combinations, radiation technologies, surgical approaches, and strategies for improving the quality of life for men undergoing prostate cancer treatment. Other trials may explore whether new or existing cancer treatments work better when combined with other forms of treatment.
Compass Oncology participates in clinical trials that not only help develop new and better ways to treat prostate cancer for our patients but for patients across the country as well.
Clinical trials are completely voluntary, and only you and your prostate cancer specialist can decide if you could benefit from participation. However, it is important to understand that there is a protocol set in place that determines who is eligible to participate. These guidelines are in place to identify appropriate participants and keep them safe. Criteria is based on a variety of factors, including age, gender, previous treatment history, current overall health, and the stage of prostate cancer. In order to participate in a clinical trial, you must qualify for the study. A member of the Compass Oncology research team will guide you through the process to see if you qualify for a particular prostate cancer research trial.
Keep in mind that clinical trials offer both advantages and disadvantages. If a research trial is suggested for you, you should take time to discuss the pros and cons with your prostate cancer doctor, other cancer care team members, and also with family and close friends.
Compass Oncology participates in clinical trials through Sarah Cannon Research Institute (SCRI), a joint venture with US Oncology Research and one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted more than 600 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.
Currently, clinical trials for prostate cancer are available at select Compass Oncology locations, including Tualatin and Portland, OR, and Vancouver, WA. Please ask your prostate cancer doctor for more information on participating in these prostate cancer research trials or if you would like to learn more about our other clinical trials. You can also view a complete list of all of the prostate cancer trials available through Compass Oncology.